How to achieve label-free images without compromising on resolution?

Online Event – Aired on March 7!

Presentation

What’s the difference between holotomography, phase contrast, and quantitative phase imaging? These three imaging techniques are all based on the same label-free principle but can provide differing levels of resolution. This video compares these technologies and their uses in live-cell imaging, from cell counting, to high-content phenotypic analysis.

This video is part of the miniseries Discover label-free imaging technology with Nanolive.
What is holotomography, how does it work and what benefits does this live-cell imaging approach bring to fundamental research and drug development? This miniseries dives into the technology behind Nanolive’s high-content live cell images and explains how holotomography is essential for providing deep phenotypic insights into cellular responses.

You may be interested in this series if you:

  • Are working on preclinical drug development in the biopharmaceutical industry
  • Are an academic research scientist
  • Want to understand drug toxicity and safety without the bias of labels
  • Have a curious mindset and want to learn more about imaging technologies

Read our latest news

Newsletter October 2024: Investigative toxicology without labels

Newsletter October 2024: Investigative toxicology without labels

Welcome to the October edition of the AI for Live Cell Insights Newsletter, bringing you the latest live cell analyses powering drug discovery and cosmetics development. Each month, we will explore a new application of AI-based cellular analysis for label-free live...

September 2024: High-content imaging for kidney disease research

September 2024: High-content imaging for kidney disease research

Welcome to the September edition of the AI for Live Cell Insights Newsletter, bringing you the latest live cell analyses powering drug discovery and cosmetics development. Each month, we will explore a new application of cellular analysis for label-free live cell...

Subscribe to our newsletter